NICE holds line against Tyverb, Herceptin use; Watson sales rocket 62% on copycat Lipitor;

@FiercePharma: Obama budget doesn't just have more industry money for FDA. Higher Medicare/Medicaid rebates, too. $156B worth, in fact. Report | Follow @FiercePharma

> The U.K.'s cost-effectiveness watchdog held firm on its rejection of GlaxoSmithKline's ($GSK) Tyverb and Roche's ($RHHBY) Herceptin for use in combination with hormone therapy for breast cancer patients. Item

> Watson Pharmaceuticals ($WPI) boosted quarterly profits to $94.8 million and hiked its 2012 earnings forecast as generic versions of Pfizer's ($PFE) Lipitor and Johnson & Johnson's ($JNJ) Concerta fueled big increases in sales. Report

> Amylin Pharmaceuticals ($AMLN) said its newly approved diabetes drug Bydureon is now available in U.S. pharmacies. Story

> Actelion is looking for steady profits this year as its sales of the lung drug Tracleer lose ground to a rival from Gilead Sciences ($GILD). Article

Biotech News

@FierceBiotech: Gates Foundation investing in biomarker research to aid TB diagnosis in developing countries. Release | Follow @FierceBiotech

@JohnCFierce: Gilman's Stromedix snagged by Biogen for $75M upfront, $487M in milestones. Release | Follow @JohnCFierce

@RyanMFierce: Novartis' MS pill showed promise in a mouse study for treating Lou Gehrig's. ALS patients will line up for PhI. Article | Follow @RyanMFierce

@FierceMedDev: FDA: New Jersey company agrees to halt production of unapproved dental devices. Release | Follow @FierceMedDev

@MarkHFierce: Radiation treatments can transform breast cancer cells into treatment-resistant breast cancer stem cells. Fascinating. Release | Follow @MarkHFierce

> The best of times, the worst of times? Piece

> Pioneering stem cell therapy mends damaged heart tissue in patients. More

Research News

> Drug briefly reversed Huntington's-related motor skills decline. News

> Obama seeks $156M to boost Alzheimer's research through 2013. Item

> Key protein appears to kill off HIV food supply in certain cells. Story

> Curcumin, in Indian curry spice, may beat down prostate tumors. More

> Umbilical cord stem cells may restore infants' hearing. Article

Manufacturing News

> Federal charges filed against Dallas compounding pharmacy. Story

> South Africa, Lonza partner on $210 million API facility. News

> Ben Venue can't say when crucial cancer drug will be available. Piece

> Dramatic decrease in pharma cargo thefts seen in 2011. Report

> Hospira beefs up quality management team. Article

> FDA asks heparin makers to test APIs for contaminants, including BSE. Item

And Finally... Pet owners with chronic diseases seem to have healthier hearts than people living solo, a study found. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.